Chinese yellow wine inhibits production of homocysteine-induced extracellular matrix metalloproteinase-2 in cultured rat vascular smooth muscle cells

Clinical Nutrition

Volumn 26, Issue 3, 2007, Pages 348-354

  Guo, Hangyuan ^a,b   Wang, Ping ^a   You, Binquan ^a   Xing, Yangbo ^a   Lee, Jong Dae ^b  

^a SHAOXING UNIVERSITY   (China)

^b UNIVERSITY OF FUKUI   (Japan)

Author keywords

Atherosclerosis; Homocysteine; Matrix metalloproteinase; Smooth muscle cell; Yellow wine

Indexed keywords

GELATINASE A; HOMOCYSTEINE;

ALCOHOLIC BEVERAGE; ANIMAL CELL; AORTA; ARTICLE; CARDIOVASCULAR SYSTEM; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME RELEASE; ENZYME SYNTHESIS; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; TIME; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; HOMOCYSTEINE; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; WINE;

EID: 34248523520     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2007.01.007     Document Type: Article

References (41)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362 (1993) 801-809
2. Zempo N., Koyama N., Kenagy R.D., Lea H.J., and Clowes A.W. Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor. Arterioscler Thromb Vasc Biol 16 (1996) 28-33
3. Brown D.L., Hibbs M.S., Kearney M., Loushin C., and Isner J.M. Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina. Circulation 91 (1995) 2125-2131
4. Uzui H., Lee J.D., Shimizu H., Tsutani H., and Ueda T. The role of protein-tyrosine phosphorylation and gelatinase production in the migration and proliferation of smooth muscle cells. Atherosclerosis 149 (2000) 51-59
5. Dollery C.M., McEwan J.R., and Henney A.M. Matrix metalloproteinases and cardiovascular disease. Circ Res 77 (1995) 863-868
6. Virdis A., Ghiadoni L., Salvetti G., Versari D., Taddei S., and Salvett A. Hyperhomocyst(e)inemia: is this a novel risk factor in hypertension?. J Nephrol 15 4 (2002) 414-421
7. Graham I.M., Daly I.E., Refsum H.M., et al. Plasma Hcy as a risk factor for vascular disease: The European Concerted Action Project. JAMA 277 (1997) 1775-1781
8. Renaud S.C., Gueguen R., Schenker J., and d'Houtaud A. Alcohol and mortality in middle-aged men from eastern France. Epidemiology 9 (1998) 184-188
9. Gronbaek M., Becker U., Johansen D., et al. Type of alcohol consumed and mortality from all causes, coronary heart disease, and cancer. Ann Intern Med 133 (2000) 411-419
10. Vinson J.A., Teufel K., and Wu N. Red wine, dealcoholized red wine, and especially grape juice, inhibit atherosclerosis in a hamster model. Atherosclerosis 156 (2001) 67-72
11. Hayek T., Fuhrman B., Vaya J., et al. Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arterioscler Thromb Vasc Biol 17 (1997) 2744-2752
12. da Luz P.L., Serrano Jr. C.V., Chacra A.P., et al. The effect of red wine on experimental atherosclerosis: lipid-independent protection. Exp Mol Pathol 65 (1999) 150-159
13. Tsukada T., Tippens D., Gordon D., Ross R., and Gown A.M. HHF35, a muscle-actin-specific monoclonal antibody. I. Immunocytochemical and biochemical characterization. Am J Pathol 126 (1987) 51-60
14. Tyagi S.C., Meyer L., Schmaltz R.A., Reddy H.K., and Voelker D.J. Proteinases and restenosis in the human coronary artery: extracellular matrix production exceeds the expression of proteolytic activity. Atherosclerosis 116 (1995) 43-57
15. Pickering G., Ford C.M., Tang B., and Chow L.H. Coordinated effects of fibroblast growth factor-2 on expression of fibrillar collagens, matrix metalloproteinases, and tissue inhibitors of matrix metalloproteinases by human vascular smooth muscle cells. Evidence for repressed collagen production and activated degradative capacity. Arterioscler Thromb Vasc Biol 17 (1997) 475-482
16. Guo H., Lee J.D., Uzui H., et al. Effects of folic acid and magnesium on the production of homocysteine-induced extracellular matrix metalloproteinase-2 in cultured rat vascular smooth muscle cells. Circ J 70 (2006) 141-146
17. Liotta L.A., Steeg P.A., and Stetler-Stevenson W.G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64 (1991) 327-336
18. Foda H.D., George S., Rollo E., et al., Regulation of gelatinases in human airway smooth muscle cells: mechanism of progelatinase A activation. Am J Physiol 277 (1999) L174-L182
19. Li Z., Li L., Zielke R., et al. Increased expression of 72-kd type IV collagenase (MMP-2) in human aortic atherosclerotic lesions. Am J Pathol 148 (1996) 121-128
20. Selhub J. Homocysteine metabolism. Ann Rev Nutr 19 (1999) 217-246
21. Gerritsen T., and Waisman H.A. Homocysteinuria, an error in the metabolism of methionine. Pediatrics 33 (1964) 413-420
22. D'Angelo A., and Selhub J. Homocysteine and thrombotic disease. Blood 90 (1997) 1-11
23. Wilcken D.E., and Wilcken B. The natural history of vascular disease in homocystinuria and the effects of treatment. J Inh Metab Dis 20 (1997) 295-300
24. Stampfer M.J., Malinow M.R., Willett W.C., et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 268 (1992) 877-881
25. Kaul S., Zadeh A.A., and Shah P.K. Homocysteine hypothesis for atherothrombotic cardiovascular disease: not validated. J Am Coll Cardiol 48 (2006) 914-923
26. Bonaa K.H., Njolstad I., Ueland P.M., et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 354 (2006) 1578-1588
27. Doronzo G., Russo I., Mattiello L., Trovati M., and Anfossi G. Homocysteine rapidly increases matrix metalloproteinase-2 expression and activity in cultured human vascular smooth muscle cells. Role of phosphatidyl inositol 3-kinase and mitogen activated protein kinase pathways. Thromb Haemost 94 (2005) 1285-1293
28. Bescond A., Augier T., Chareyre C., Garcon D., Hornebeck W., and Charpiot P. Influence of homocysteine on matrix metalloproteinase-2: activation and activity. Biochem Biophys Res Commun 263 (1999) 498-503
29. Chavarria T., Rodriguez-Nieto S., Sanchez-Jimenez F., Quesada A.R., and Medina M.A. Homocysteine is a potent inhibitor of human tumor cell gelatinases. Biochem Biophys Res Commun 303 (2003) 572-575
30. Frinkelstein J.D. The metabolism of homocysteine: pathways and regulation. Eur J Pediatr 157 Suppl 2 (1998) s40-s44
31. Frankel E.N., Kanner J., German J.B., Parks E., and Kinsella J.E. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 341 (1993) 454-457
32. Wang Z., Huang Y., Zou J., Cao K., Xu Y., and Wu J.M. Effects of red wine and wine polyphenol resveratrol on platelet aggregation in vivo and in vitro. Int J Mol Med 9 (2002) 77-79
33. Feng A.N., Chen Y.L., Chen Y.T., Ding Y.Z., and Lin S.J. Red wine inhibits monocyte chemotactic protein-1 expression and modestly reduces neointimal hyperplasia after balloon injury in cholesterol-fed rabbits. Circulation 100 (1999) 2254-2259
34. Pendurthi U.R., Williams J.T., and Rao L.V. Resveratrol, a polyphenolic compound found in wine, inhibits tissue factor expression in vascular cells: a possible mechanism for the cardiovascular benefits associated with moderate consumption of wine. Arterioscler Thromb Vasc Biol 19 (1999) 419-426
35. Oak M.H., El Bedoui J., Anglard P., and Schini-Kerth V.B. Red wine polyphenolic compounds strongly inhibit pro-matrix metalloproteinase-2 expression and its activation in response to thrombin via direct inhibition of membrane type 1-matrix metalloproteinase in vascular smooth muscle ells. Circulation 110 (2004) 1861-1867
36. Inoue N., Takeshita S., Gao D., et al. Lysophosphatidylcholine increases the secretion of matrix metalloproteinase 2 through the activation of NADH/NADPH oxidase in cultured aortic endothelial cells. Atherosclerosis 155 (2001) 45-52
37. Grote K., Flach I., Luchtefeld M., et al. Mechanical stretch enhances mRNA expression and proenzyme release of matrix metalloproteinase-2 (MMP-2) via NAD(P)H oxidase-derived reactive oxygen species. Circ Res 92 (2003) e80-e86
38. Galis Z.S., Asanuma K., Godin D., and Meng X. N-Acetyl-cysteine decreases the matrix-degrading capacity of macrophage-derived foam cells: new target for antioxidant therapy?. Circulation 97 (1998) 2445-2453
39. Gorlach A., Diebold I., Schini-Kerth V.B., et al. Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: role of the p22(phox)-containing NADPH oxidase. Circ Res 89 (2001) 47-54
40. Bassus S., Herkert O., Kronemann N., et al. Thrombin causes vascular endothelial growth factor expression in vascular smooth muscle cells: role of reactive oxygen species. Arterioscler Thromb Vasc Biol 21 (2001) 1550-1555
41. Duthie G.G., Pedersen M.W., Gardner P.T., et al. The effect of whisky and wine consumption on total phenol content and antioxidant capacity of plasma from healthy volunteers. Eur J Clin Nutr 52 (1998) 733-736